Log in
OTCMKTS:ADDXF

Addex Therapeutics Short Interest Ratio and Short Volume

$1.65
0.00 (0.00 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.65
Now: $1.65
$1.65
50-Day Range
$1.65
MA: $1.65
$1.65
52-Week Range
$1.65
Now: $1.65
$1.65
VolumeN/A
Average VolumeN/A
Market Capitalization$43.51 million
P/E RatioN/A
Dividend YieldN/A
Beta0.47

Short Interest

Addex Therapeutics (OTCMKTS:ADDXF) Short Interest Data

Current Short Volume:400 shares
Previous Short Volume:400 shares
Change Vs. Previous Month:No Change
Dollar Volume Sold Short:$660.00
Short Interest Ratio / Days to Cover:0.0
Last Record Date:October, 30 2020
Outstanding Shares:26,370,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:0 shares
Average Trading Volume:0 shares
Today's Volume Vs. Average:NaN



Addex Therapeutics (OTCMKTS:ADDXF) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
10/30/2020400 $660.00 0.0%0.0%0$1.65
10/15/2020400 $660.00 33.3%0.0%0$1.65
9/30/2020300 $495.00 0.0%0.0%0$1.65
9/15/2020300 $495.00 0.0%0.0%3$1.65

Addex Therapeutics (OTCMKTS:ADDXF) Short Interest FAQ

speech bubbles
speech bubbles











What is Addex Therapeutics' current short interest?

Short interest is the volume of Addex Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 30th, traders have sold 400 shares of ADDXF short. 0.00% of Addex Therapeutics' shares are currently sold short. View details.

How does Addex Therapeutics' short interest compare to its competitors?

0.00% of Addex Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Addex Therapeutics: Minerva Neurosciences, Inc. (8.23%), Sol-Gel Technologies Ltd. (1.57%), Tiziana Life Sciences PLC (0.00%), Checkpoint Therapeutics, Inc. (0.00%), ContraFect Co. (6.29%), LifeVantage Co. (5.98%), vTv Therapeutics Inc. (15.25%), Sierra Oncology, Inc. (0.25%), Sesen Bio, Inc. (0.00%), and AVEO Pharmaceuticals, Inc. (4.73%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.66 billion), Aon Plc ($3.83 billion), Analog Devices, Inc. ($3.33 billion), ViacomCBS Inc. ($3.13 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.85 billion), Uber Technologies, Inc. ($2.80 billion), Moderna, Inc. ($2.26 billion), Simon Property Group, Inc. ($2.02 billion), and International Flavors & Fragrances Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short Addex Therapeutics stock?

Short selling ADDXF is an investing strategy that aims to generate trading profit from Addex Therapeutics as its price is falling. To short Addex Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Addex Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Addex Therapeutics?

A short squeeze for Addex Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADDXF, which in turn drives the price of the stock up even further.

How often is Addex Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADDXF, twice per month. The most recent reporting period available is October, 30 2020.


This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.